by Institute of Cancer Research Colorised scanning electron micrograph of a natural killer cell from a human donor. Credit: NIAID. CC BY 2.0 A new type of immunotherapy making use of the immune system’s “natural killer cells” could offer potential against a range of cancers that can evade current treatments, early results from a phase I trial...
